Nasdaq-listed oncology firm launches regional HQ in Singapore
Guardant Health AMEA has distributorships in key markets including S-E Asia, HK, NZ and Israel
Add BT as a preferred source
Claudia Chong
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
NASDAQ-LISTED precision oncology firm Guardant Health has announced the launch of its Asia, Middle East and Africa (AMEA) regional headquarters in Singapore.
Guardant Health helps medical professionals decide which therapy may be effective for advanced stage cancer patients with solid tumours. It does so through liquid biopsy tests for comprehensive genomic profiling and big data analytics. A liquid biopsy is a test done on a sample of blood to look for cancer cells.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
